[1] Wu H, Xin L, Lin JH, et al.Association between sedation and small neoplasm detection during diagnostic esophagogastroduodenoscopy: a propensity score-matched retrospective study[J]. Scandinavian Journal of Gastroenterology, 2022, 57(5): 603-609. [2] Zhou J, Li Z, Ji R, et al.Influence of Sedation on the Detection Rate of Early Cancer and Precancerous Lesions During Diagnostic Upper Gastrointestinal Endoscopies: A Multicenter Retrospective Study[J]. American Journal of Gastroenterology, 2021, 116(6): 1230-1237. [3] Lee HJ, Kim B, Kim DW, et al.Does Sedation Affect Examination of Esophagogastric Junction during Upper Endoscopy?[J]. Yonsei Medical Journal, 2015, 56(6): 1566-1571. [4] Kim ES.Negative impact of sedation on esophagogastric junction evaluation during esophagogastroduodenoscopy[J]. World Journal of Gastroenterology, 2014, 20(18): 5527-5532. [5] Meining A, Semmler V, Kassem A, et al.The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam[J]. Endoscopy, 2007, 39(4): 345-349. [6] Chen Z, Liu L, Tu J, et al.Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy[J]. PLOS ONE, 2017, 12(6): e0179490. [7] Morita A, Nakayama Y, Horiuchi A, et al.Stimulating peristalsis improves esophagogastric junction observation during sedated esophagogastroduodenoscopy in children and adolescents[J]. Acta Gastro Enterologica Belgica, 2022, 85(1): 15-19. [8] 国家消化系疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,中华医学会消化病学分会幽门螺杆菌学组,等. 中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J]. 中华消化杂志,2020,40(11):731-741. [9] 国家消化系统疾病临床医学研究中心(上海),中华医学会消化内镜学分会,中国医师协会内镜医师分会消化内镜专业委员会,等. 中国食管鳞癌癌前状态及癌前病变诊治策略专家共识[J]. 中华消化内镜杂志,2020,37(12):853-867. [10] 赫捷,陈万青,李兆申,等. 中国食管癌筛查与早诊早治指南(2022,北京)[J]. 中华肿瘤杂志,2022,44(6):491-522. [11] 陈龙奇,胡建昆,季加孚,等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版)[J]. 中华胃肠外科杂志,2018, 21(9):961-975. [12] 李鹏,王拥军,陈光勇,等. 中国巴雷特食管及其早期腺癌筛查与诊治共识(2017万宁)[J]. 中国实用内科杂志,2017,37(9):798-809. [13] 刘琳刚. 无痛胃镜与普通胃镜对贲门暴露程度影响及对策研究[D]. 浙江:浙江大学,2016. [14] 吴会晓,唐旭东,柯俊,等. 无痛胃镜与普通胃镜上消化道疾病检出率分析[J]. 现代消化及介入诊疗,2020,25(10):1359-1363. [15] Matsuo Y, Yasuda H, Itoh F.Investigation of factors affecting endoscopic observation for esophagogastric junction[J]. Journal of Gastrointestinal Cancer Screening, 2017, 55(5): 640-646. [16] Jung H, Kim HJ, Choi E, et al.Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.[J]. PloS one, 2021, 16(8): e0255016. [17] Yun HW, Shim KN, Na SK, et al.Comparison between the Effectiveness of Oral Phloroglucin and Cimetropium Bromide as Premedication for Diagnostic Esophagogastroduodenoscopy: An Open-Label, Randomized, Comparative Study[J]. Clinical Endoscopy, 2015, 48(1): 48. [18] 熊丽丽,姬劲峰. 间苯三酚对胃镜检查患者的心血管系统的影响分析[J]. 海峡药学,2017,29(2):98-99. [19] Jung P, Park SB, Kim HW, et al.Cimetropium bromide does not improve polyp and adenoma detection during colonoscope withdrawal[J]. Medicine, 2018, 97(25): e11253. [20] Kim SY, Park JM, Cho HS, et al.Assessment of Cimetropium Bromide Use for the Detection of Gastric Neoplasms During Esophagogastroduodenoscopy[J]. JAMA Network Open, 2022, 5(3): e223827. [21] Omata F, Kumakura Y, Ishii N, et al.Noneffectiveness of scopolamine for facilitating detection of upper gastrointestinal neoplasia during screening esophagogastroduodenoscopy: propensity score-matched study[J]. Endoscopy, 2020, 52(7): 556-562. |